DEVELOPICK™: High-throughput development assessment to enable efficient formulation development
While speed to market remains critical in drug development, the pharma industry is increasingly focused on maximizing the effectiveness of early-stage candidate assessments. In this whitepaper, Derrick Katayama, Lead Scientist in Formulation Development and Heonchang Lim, Head of Formulation Development, provide insights on how Samsung Biologics’ developability assessment platform, DEVELOPICK™ can help mitigate risks by facilitating the identification of potential issues.
While speed to market remains critical in drug development, the pharma industry is increasingly focused on maximizing the effectiveness of early-stage candidate assessments. In this whitepaper, Derrick Katayama, Lead Scientist in Formulation Development and Heonchang Lim, Head of Formulation Development, provide insights on how Samsung Biologics’ developability assessment platform, DEVELOPICK™ can help mitigate risks by facilitating the identification of potential issues.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO